Mir Youssef, van Lier Johan E, Paquette Benoit, Houde Daniel
Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, Canada.
Photochem Photobiol. 2008 Sep-Oct;84(5):1182-6. doi: 10.1111/j.1751-1097.2008.00311.x. Epub 2008 Mar 7.
Photodynamic therapy (PDT), the use of light-activated drugs, is a promising treatment of cancer as well as several nonmalignant conditions. However, the efficacy of one-photon (1-gamma) PDT is limited by hypoxia, which can prevent the production of the cytotoxic singlet oxygen ((1)O(2)) species, leading to tumor resistance to PDT. To solve this problem, we propose an irradiation protocol based on a simultaneous, two-photon (2-gamma) excitation of the photosensitizer (Ps). Excitation of the Ps triplet state leads to an upper excited triplet state T(n) with distinct photochemical properties, which could inflict biologic damage independent of the presence of molecular oxygen. To determine the potential of a 2-gamma excitation process, Jurkat cells were incubated with zinc or copper phthalocyanine tetrasulfonate (ZnPcS(4) or CuPcS(4)). ZnPcS(4) is a potent (1)O(2) generator in 1-gamma PDT, while CuPcS(4) is inactive under these conditions. Jurkat cells incubated with either ZnPcS(4) or CuPcS(4) were exposed to a 670 nm continuous laser (1-gamma PDT), 532 nm pulsed-laser light (2-gamma PDT), or a combination of 532 and 670 nm (2-gamma PDT). The efficacy of ZnPcS(4) to photoinactivate the Jurkat cells decreased as the concentration of oxygen decreased for both the 1-gamma and 2-gamma protocols. In the case of CuPcS(4), cell phototoxicity was measured only following 2-gamma irradiation, and its efficacy also decreased at a lower oxygen concentration. Our results suggest that for CuPcS(4) the T(n) excited state can be populated after 2-gamma irradiation at 532 nm or the combination of 532 and 670 nm light. Dependency of phototoxicity upon aerobic conditions for both 1-gamma and 2-gamma PDT suggests that reactive oxygen species play an important role in 1-gamma and 2-gamma PDT.
光动力疗法(PDT),即使用光激活药物,是一种治疗癌症以及多种非恶性疾病的有前景的方法。然而,单光子(1-γ)PDT的疗效受到缺氧的限制,缺氧会阻止细胞毒性单线态氧((1)O(2))的产生,导致肿瘤对PDT产生抗性。为了解决这个问题,我们提出了一种基于同时双光子(2-γ)激发光敏剂(Ps)的照射方案。Ps三重态的激发会导致具有独特光化学性质的上激发三重态T(n),它可以在不依赖分子氧存在的情况下造成生物损伤。为了确定双光子激发过程的潜力,将Jurkat细胞与四磺酸锌酞菁或四磺酸铜酞菁(ZnPcS(4)或CuPcS(4))一起孵育。ZnPcS(4)是1-γ PDT中一种有效的(1)O(2)产生剂,而CuPcS(4)在这些条件下无活性。用ZnPcS(4)或CuPcS(4)孵育的Jurkat细胞暴露于670nm连续激光(1-γ PDT)、532nm脉冲激光(2-γ PDT)或532和670nm的组合光(2-γ PDT)下。对于1-γ和2-γ方案,随着氧浓度降低,ZnPcS(4)使Jurkat细胞光灭活的效力均降低。对于CuPcS(4),仅在双光子照射后测量细胞光毒性,并且在较低氧浓度下其效力也降低。我们的结果表明,对于CuPcS(4),在532nm双光子照射或532和670nm光组合照射后可以形成T(n)激发态。1-γ和2-γ PDT的光毒性对需氧条件的依赖性表明活性氧在1-γ和2-γ PDT中起重要作用。